Table 3.
Access site complications
| Retrograde (n=66,393) | Antegrade (n=6,070) | P Value* | |
|---|---|---|---|
|
| |||
| Access Site Complications | |||
| Hematoma | 0.002 | ||
| No | 65,192 (98.2%) | 5,917 (97.5%) | |
| Minor | 898 (1.4%) | 113 (1.9%) | |
| Transfusion | 140 (0.2%) | 21 (0.4%) | |
| Thrombin Injection | 52 (0.1%) | 4 (0.1%) | |
| Operative Treatment | 111 (0.2%) | 15 (0.3%) | |
| Any Hematoma | 1,201 (1.8%) | 153 (2.5%) | <0.001 |
| Hematoma Requiring Intervention | 303 (0.5%) | 40 (0.7%) | 0.032 |
| Access Site Stenosis or Occlusion | 150 (0.2%) | 19 (0.3%) | 0.208 |
Values as n (%).
*
Calculated using a X2 test.